List of works - Sara Monti

20 years of experience with tumour necrosis factor inhibitors: what have we learned?

scientific article published on 01 October 2018

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

scientific article published on 03 July 2019

ANCA-associated vasculitis in childhood: recent advances.

scientific article

Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management

scientific article published on 01 January 2019

Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes

scientific article published on 23 May 2020

Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comm

scientific article published on 23 April 2020

Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak

scientific article published on 05 June 2020

Chronic pain: the burden of disease and treatment innovations

scientific article

Circulating suPAR levels are affected by glomerular filtration rate and proteinuria in primary and secondary glomerulonephritis

scientific article published on 04 September 2014

Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated wi

scientific article published on 26 June 2020

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

scientific article published on 02 April 2020

Clinical spectrum of anti-Jo-1-associated disease.

scientific article published on 8 August 2017

Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al

scientific article published on 20 May 2020

Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Gui

scientific article published on 30 April 2020

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.

scientific article

How I treat idiopathic patients with inflammatory myopathies in the clinical practice

scientific article published on 02 August 2017

Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis

scientific article published on 24 May 2020

Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series.

scientific article published on March 2015

Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case

scientific article published on 18 June 2020

Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis

scientific article published on 23 September 2019

Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al

scientific article published on 30 April 2020

Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients

scientific article published on 13 May 2014

Perivascular fibrosis and IgG4-related disease: a case report

scientific article published on 06 November 2014

Pneumocephalus due to granulomatosis with polyangiitis

scientific article published on 09 September 2014

Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.

scientific article published on 7 September 2017

Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic dr

scientific article published on 15 May 2020

Randomized controlled trials and real-world data: differences and similarities to untangle literature data

scientific article published on 01 October 2018

Response to: 'Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic' by Lecler et al

scientific article published on 22 September 2020

Rheumatoid arthritis treatment: the earlier the better to prevent joint damage

scientific article

Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

scientific article

Spinal non-Hodgkin's lymphoma mimicking a flare of disease in a patient with ankylosing spondylitis treated with anti-TNF agents: case report and review of the literature

scientific article published on 05 April 2014

Successful treatment with baricitinb in a patient with refractory cutaneous dermatomyositis

scientific article published on 30 April 2020

Switching from Intravenous to Subcutaneous Formulation of Abatacept: Different Results in a Series of 21 Patients

scientific article published on 01 October 2015

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis

scientific article published on 16 September 2019

The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheu

scientific article published on 27 April 2020

The impact of disease extent and severity detected by quantitative ultrasound analysis in the diagnosis and outcome of giant cell arteritis

scientific article published on 17 December 2019

The multifaceted aspects of interstitial lung disease in rheumatoid arthritis

scientific article

The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice

scientific article

The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature

scientific article published on 03 August 2018

The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist.

scientific article

List of works by Sara Monti

20 years of experience with tumour necrosis factor inhibitors: what have we learned?

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

ANCA-associated vasculitis in childhood: recent advances.

Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management

Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes

Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comm

Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak

Chronic pain: the burden of disease and treatment innovations

Circulating suPAR levels are affected by glomerular filtration rate and proteinuria in primary and secondary glomerulonephritis

Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated wi

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

Clinical spectrum of anti-Jo-1-associated disease.

Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al

Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Gui

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.

How I treat idiopathic patients with inflammatory myopathies in the clinical practice

Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis

Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series.

Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case

Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis

Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al

Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients

Perivascular fibrosis and IgG4-related disease: a case report

Pneumocephalus due to granulomatosis with polyangiitis

Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.

Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic dr

Randomized controlled trials and real-world data: differences and similarities to untangle literature data

Response to: 'Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic' by Lecler et al

Rheumatoid arthritis treatment: the earlier the better to prevent joint damage

Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

Spinal non-Hodgkin's lymphoma mimicking a flare of disease in a patient with ankylosing spondylitis treated with anti-TNF agents: case report and review of the literature

Successful treatment with baricitinb in a patient with refractory cutaneous dermatomyositis

Switching from Intravenous to Subcutaneous Formulation of Abatacept: Different Results in a Series of 21 Patients

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis

The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheu

The impact of disease extent and severity detected by quantitative ultrasound analysis in the diagnosis and outcome of giant cell arteritis

The multifaceted aspects of interstitial lung disease in rheumatoid arthritis

The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice

The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature

The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist.